1. Parizadeh SM, Parizadeh SA, Alizade-Noghani M, Jafarzadeh-Esfehani R, Ghandehari M, Mottaghi-Moghaddam A, et al. Association between non-alcoholic fatty liver disease and colorectal cancer. Expert Rev Gastroenterol Hepatol. 2019; 13(7): 633-41.
2. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008; 48 Suppl 1: S104-12
3. Stefan N, Häring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019; 7(4): 313-24.
4. Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016; 64(5): 1577-86.
5. Ahn JS, Sinn DH, Min YW, Hong SN, Kim HS, Jung SH, et al. Non‐alcoholic fatty liver diseases and risk of colorectal neoplasia. Aliment Pharmacol Ther. 2017; 45(2): 345-53.
6. Sweet PH, Khoo T, Nguyen S. Nonalcoholic Fatty Liver Disease. Prim Care. 2017; 44(4): 599-607.
7. Hashimoto E, Yatsuji S, Kaneda H, Yoshioka Y, Taniai M, Tokushige K, et al. The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease. Hepatol Res. 2005; 33(2): 72-6.
8. Wong GLH. Update of liver fibrosis and steatosis with transient elastography (Fibroscan). Gastroenterol Rep (Oxf). 2013; 1(1): 19-26.
9. Engin A. Non-Alcoholic Fatty Liver Disease. Adv Exp Med Biol. 2017; 960: 443-467.
10. Cheung O, Kapoor A, Puri P, Sistrun S, Luketic VA, Sargeant CC, et al. The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. Hepatology. 2007; 46(4): 1091-100.
11. Gastaldelli A. Fatty liver disease: the hepatic manifestation of metabolic syndrome. Hypertens Res. 2010; 33(6): 546-7.
12. Rocha R, Cotrim HP, Carvalho FM, Siqueira AC, Braga H, Freitas LA. Body mass index and waist circumference in non-alcoholic fatty liver disease. J Hum Nutr Diet. 2005; 18(5): 365-70.
13. van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, et al. Visceral fat: A key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008; 48(2): 449-57.
14. Weta IW, Mahadewa TG, Sutirtayasa WP, Subawa A, Sitanggang FP, Widyadharma IPE. The Comparison of Simple Anthropometric and Biochemical Parameters for Predicting Liver Steatosis in Obese Balinese Young Women. Open Access Maced J Med Sci. 2018; 6(11): 2062-6.
15. Monteiro PA, Antunes BdMM, Silveira LS, Christofaro DGD, Fernandes RA, Freitas IF. Body composition variables as predictors of NAFLD by ultrasound in obese children and adolescents. BMC Pediatr. 2014; 14(1): 25.
16. Maher JJ. Trunk fat as a determinant of liver disease. Gastroenterology. 2010; 138(4): 1244-6.
17. Ruhl CE, Everhart JE. Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States. Gastroenterology. 2010; 138(4): 1346-56.
18. Ju DY, Choe YG, Cho YK, Shin DS, Yoo SH, Yim SH, et al. The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults. Clin Mol Hepatol. 2013; 19(2): 140-7.
19. Motamed N, Sohrabi M, Ajdarkosh H, Hemmasi G, Maadi M, Sayeedian FS, et al. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World J Gastroenterol. 2016; 22(10): 3023-30.
20. Clemente APG, Netto BDM, de Carvalho-Ferreira JP, da Silveira Campos RM, de Piano Ganen A, Tock L, et al. Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents. Rev Paul Pediatr. 2016; 34(1): 47-55.
21. Yun KE, Nam GE, Lim J, Park HS, Chang Y, Jung H-S, et al. Waist gain is associated with a higher incidence of nonalcoholic fatty liver disease in Korean adults: a cohort study. PLoS One. 2016; 11(7): e0158710.